Investors / filer profile

Opaleye Management Inc.

active in 7 companies · 2 of 5 positions beat the S&P ~6mo later

Pro
Bought: Pro
Sold: 98
Filings: 7
Companies: 2026-09-11
Last filed

EDGAR · CIK 0001595855 ↗

Track record

How each disclosed position did against the S&P ~6 months later

The outcome curve and every position's resultPro →

-1.7%

median move per position

+12.8%

S&P 500 median, same spans

2 of 5

beat the S&P ~6mo later

2 positions still inside the ~6-month window — not scored yet.

Disclosed positions

Estimated from their latest filings — positions may have changed since

Estimated positions from their latest filingsPro →

Activity

Open-market buy & sell volume

BuySell

Total +$16.67M bought · −$12.02M sold

All filings on record

Every Form 4 transaction we track for this filer


SLGLSol-Gel Technologies Ltd.	Buy $98.5K · 1,493 sh	2026-09-11	—
SLGLSol-Gel Technologies Ltd.	Buy $108.9K · 1,631 sh	2026-09-10	—
GRCEGrace Therapeutics, Inc.	Buy $12.2K · 5,836 sh	2026-09-09	—
SLGLSol-Gel Technologies Ltd.	Buy $212.8K · 3,097 sh	2026-09-09	—
GRCEGrace Therapeutics, Inc.	Buy $19.7K · 9,393 sh	2026-09-08	—
SLGLSol-Gel Technologies Ltd.	Buy $32.7K · 471 sh	2026-09-08	—
SLGLSol-Gel Technologies Ltd.	Buy $233.0K · 3,390 sh	2026-09-08	—
SLGLSol-Gel Technologies Ltd.	Buy $144.9K · 2,100 sh	2026-09-04	—
SLGLSol-Gel Technologies Ltd.	Buy $63.8K · 918 sh	2026-09-04	—
SLGLSol-Gel Technologies Ltd.	Buy $15.0K · 217 sh	2026-08-31	—

SLGLBuy

2026-09-11 · Sol-Gel Technologies Ltd.

$98.5K

—

SLGLBuy

2026-09-10 · Sol-Gel Technologies Ltd.

$108.9K

—

GRCEBuy

2026-09-09 · Grace Therapeutics, Inc.

$12.2K

—

SLGLBuy

2026-09-09 · Sol-Gel Technologies Ltd.

$212.8K

—

GRCEBuy

2026-09-08 · Grace Therapeutics, Inc.

$19.7K

—

SLGLBuy

2026-09-08 · Sol-Gel Technologies Ltd.

$32.7K

—

SLGLBuy

2026-09-08 · Sol-Gel Technologies Ltd.

$233.0K

—

SLGLBuy

2026-09-04 · Sol-Gel Technologies Ltd.

$144.9K

—

SLGLBuy

2026-09-04 · Sol-Gel Technologies Ltd.

$63.8K

—

SLGLBuy

2026-08-31 · Sol-Gel Technologies Ltd.

$15.0K

—

Newest 10 of 98 filingsEvery Form 4 on record, with outcomesPro →

Outcomes measure each position — the first buy in a stock and every buy within 182 days — against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.